Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Baird Medical Investment Holdings Limited (BDMD) operates in the medical devices sector, focusing on innovative healthcare solutions primarily in North America and Europe. The company has a competitive edge through its proprietary technologies and strong intellectual property portfolio, although it currently faces significant operational challenges.
BDMD generates revenue through the sale of advanced medical devices, leveraging its proprietary technologies to command premium pricing. The company also licenses its technology to other firms, creating additional revenue streams. Its competitive advantages include a strong patent portfolio and established relationships with healthcare providers.
Regulatory approvals for new medical devices
Partnerships or licensing agreements with larger healthcare firms
Changes in healthcare reimbursement policies
Market adoption rates of new technologies
Technological disruption from emerging medical technologies
Regulatory changes impacting product approvals and market access
Intense competition from established medical device manufacturers
Potential for new entrants with disruptive technologies
Negative operating margins leading to liquidity concerns
High reliance on external financing for R&D and operational costs
moderate - The healthcare sector is somewhat insulated from economic downturns, but demand for elective procedures can be sensitive to consumer spending.
High interest rates can increase financing costs for R&D and expansion, negatively impacting profitability and valuation multiples.
minimal - The company has a manageable debt-to-equity ratio, reducing its reliance on credit markets.
growth - Investors looking for high-risk, high-reward opportunities in the healthcare sector.
high - The stock has exhibited significant volatility, with a 1-year return of -68.9%.